International Journal of Clinical Science and Medical Research

The COVID-19 pandemic had an unprecedented impact on healthcare systems and the global population. Investigating cardiac complications following COVID-19 recovery holds vital clinical importance, given its scope in the development of post-discharge monitoring programs for patients, as well as the economic and healthcare implication involved. The scoping review aimed to provide a summary of the current and available evidence related to cardiovascular sequelae in adult patients who had COVID-19. Research evidence, published in the last three years (2021 to October 2023), was retrieved in English and Spanish. A total of 746 articles were identified and only 12 that met the inclusion criteria were selected for this review. The most common persistent symptoms reported were dyspnea and fatigue, followed by palpitations and chest pain. Cardiac complications of SARS-CoV-2 virus infection include myocarditis, vasculitis, acute coronary syndrome, right ventricular dysfunction, pericarditis and myocardial infarction. Although the COVID-19 health emergency has ended on an international scale, the consequences of SARS-CoV-2 infection, particularly the cardiovascular sequelae, remain a public health concern due to the associated morbidity and mortality. Documentation and knowledge of the main characteristics of cardiovascular sequelae is crucial for their extent in the development of post-discharge monitoring programs for patients with COVID-19, as well as for health and economic implications.

COVID-19, SARS-CoV-2, Complications, Post-Acute COVID-19 Syndrome, Cardiovascular Diseases

1. Khetpal V, Berkowitz J, Vijayakumar S, Choudary G, Mukand JA, Rudolph JL, et al. Long-term Cardiovascular Manifestations and Complications of COVID-19: Spectrumand Approach to Diagnosis and Management. R I Med J (2013). 2022;105(7):16-22. http://www.ncbi.nlm.nih.gov/pubmed/35930485
2. Raman B, Bluemke DA, Lüscher TF, Neubauer S. Long COVID: Post-Acute sequelaeof COVID-19 with a cardiovascular focus. Eur Heart J. 2022;43(11):1157- 1172. doi:10.1093/eurheartj/ehac031
3. Desai AD, Lavelle M, Boursiquot BC, Wan EY. Long-term complications of COVID-19. Am J Physiol - Cell Physiol. 2022;322(1):C1-C11. doi:10.1152/AJPCELL.00375.2021
4. Tricco AC, Lillie E, Zarin W, O´Brien KK, Colquhoun H, Levac  D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Ann InternMed. 2018;169(7):467-473. doi:10.7326/M18-0850
5. XieY, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19.Nat Med. 2022;28(3):583-590. doi:10.1038/s41591-022-01689-3
6. WangW, Wang CY, Wang SI, Wei JCC. Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: A retrospective cohort study from the TriNetX US collaborative networks. eClinicalMedicine. 2022;53(110):101619. doi:10.1016/j.eclinm.2022.101619
7. Kunal S, Bagarhatta P, Palleda GM, Bansal A, Batra V, Daga MK, et al. Role of cardiovascular magnetic resonance imaging in COVID-19 recovered patients: A short-term follow-up study. Echocardiography. 2022;39(11):1401-1411. doi:10.1111/echo.15466
8. Ortega-Paz L, Arévalos V, Fernández-Rodríguez D, Jiménez-Díaz V, Bañeras J, Campo G, etal. One-year cardiovascular outcomes after coronavirus disease 2019: The cardiovascular COVID-19 registry. PLoS One. 2022;17(12 December):1-18. doi:10.1371/journal.pone.0279333
9. González-Hermosillo J, Galarza J, Fermín OV, González JMN, Tostado LMFÁ, Lozano MAE, et al. Exaggerated blood pressure elevation in response to orthostatic challenge, a post-acute sequelaeof SARS-CoV-2 infection (PASC) after hospitalization. Auton Neurosci Basic Clin. 2023;247. doi:https://doi.org/10.1016/j.autneu.2023.103094
10. Hamdy RM, Abdelaziz OH, Shamsseldain HE, Eltrawy HH. Functional outcomesin post Covid-19 patients with persistent dyspnea: multidisciplinary approach. Int J Cardiovasc Imaging. 2023;39(6):1115-1122. doi:10.1007/s10554-023-02819-9
11. Mancini D, Brunjes D, Lala A, Trivieri M, Contreras J, Natelson B. Use of Cardiopulmonary Stress Testing for Patients With Unexplained DyspneaPost– Coronavirus Disease. JACC Hear Fail. 2021;9(12):927-937. doi:https://doi.org/10.1016/j.jchf.2021.10.002
12. Aranyó J, BazanV, Lladós G, Dominguez MJ, Bisbal F, Massanella M, et al. Inappropriate sinus tachycardia in post-COVID- 19 syndrome. Sci Rep. 2022;12(1):1-9. doi:10.1038/s41598-021-03831-6
13. Gorecka M, Jex N, Thirunavukarasu S, Chowdhary A, Corrado J, Davison J, et al. Cardiovascular magnetic resonance imaging and spectroscopy in clinicallong-COVID-19 syndrome: a prospective case– control study. J Cardiovasc Magn Reson. 2022;24(1):1-11. doi:10.1186/s12968-022- 00887-9
14. Clark DE, Dendy JM, Li DL, Crum K, Dixon D, George-Durrett K, et al. Cardiovascular magnetic resonance evaluation of soldiers after recovery from symptomatic SARS-CoV-2 infection: a case–control study of cardiovascular post-acute sequelae of SARS-CoV-2 infection (CV PASC). J Cardiovasc Magn Reson. 2021;23(1):1-9. doi:10.1186/s12968-021-00798-1
15. Wiemken TL, McGrath LJ, Andersen KM, Khan F, Malhotra D, Alfred T, et al. Coronavirus Disease 2019 Severity and Risk of Subsequent Cardiovascular Events. Clin Infect Dis. 2023;76(3):E42- E50. doi:10.1093/cid/ciac661
16. Mahmoud Z, East L, Gleva M, Woodard PK, Lavine K, Verma AK. Cardiovascular symptom phenotypes of post-acute sequelae of SARS-CoV-2. Int J Cardiol. 2022;366:35-41. doi:https://doi.org/10.1016/j.ijcard.2022.07.018
17. Huseynov A, Akin I, Duerschmied D, Scharf RE. Cardiac Arrhythmias in Post- COVID Syndrome: Prevalence, Pathology, Diagnosis, and Treatment. Viruses. 2023;15(2):1-15. doi:10.3390/v15020389
18. ZuinM, Rigatelli G, Roncon L, Pasquetto G, Bilato C. Risk of incident heart failure after COVID-19 recovery: a systematic review and meta-analysis. Heart Fail Rev. 2023;28(4):859-864. doi:10.1007/s10741-022-10292-0
19. Petersen SE, Friedrich MG, Leiner T, Elias MD, Ferreira VM, Fenski M, et al. Cardiovascular Magnetic Resonance for Patients With COVID-19. JACC Cardiovasc Imaging. 2022;15(4):685-699. doi:10.1016/j.jcmg.2021.08.021
20. Ruberg FL, Baggish AL, Hays AG, Jerosch-Herold M, Kim J, Ordovas KG, et al. Utilization of cardiovascular magnetic resonance (CMR) imagingfor resumption of athletic activities following COVID-19 infection: an expert consensus document on behalf of the American Heart Association Council on Cardiovascular Radiologyand Interventio. J Cardiovasc Magn Reson. 2022;24(1):1-15. doi:10.1186/s12968-022-00907-8
21. YanMZ, Yang M, Lai CL. Post-COVID-19 SyndromeComprehensive Assessment: From Clinical Diagnosis to Imaging and Biochemical-Guided Diagnosis and Management. Viruses. 2023;15(2). doi:10.3390/v15020533
22. Tabacof L, Tosto-Mancuso J, Wood J, Cortes M, Kontorovich A, McCarthy D, et al. Post-acute COVID-19 Syndrome Negatively Impacts PhysicalFunction, Cognitive Function,Health-Related Quality of Life, and Participation. Am J Phys Med Rehabil. 2022;101(1):48-52. doi:10.1097/PHM.0000000000001910
23. Ashton RE, Philips BE, Faghy M. The acute and chronic implications of the COVID-19virus on the cardiovascular systemin adults: A systematic review. Prog Cardiovasc Dis. 2023;76:31-37. doi:https://doi.org/10.1016/j.pcad.2023.01.003
24. Tobler DL, Pruzansky AJ, Naderi S, Ambrosy AP, Slade JJ. Long-Term Cardiovascular Effects of COVID-19: Emerging Data Relevant to the Cardiovascular Clinician. Curr Atheroscler Rep. 2022;24(7):563-570. doi:10.1007/s11883-022-01032-8
25. Alvarez-Moreno CA, Pineda J, BareñoA, Espitia R, Rengifo P. Long COVID-19in Latin America: Low prevalence, high resilience or low surveillance and difficulties accessing health care? Travel Med Infect Dis. 2023;51. doi:https://doi.org/10.1016/j.tmaid.2022.102492